Biomedical Engineering Reference
In-Depth Information
86. Cline H. E., Hynynen K., Hardy C. J., Watkins R. D., Schenck
J. F., Jolesz F. A. MR temperature mapping of focused ultra-
sound surgery.
Magn Reson Med
1994; 31:628-636.
87. Hynynen K., Darkazanli A., Unger E., and Schenck J. F.
MRI-guided noninvasive ultrasound surgery.
Med Phys
1993; 20:107-115.
88. Hardy C. J., Cline H. E., and Watkins R. D. One-dimensional
NMR thermal mapping of focused ultrasound surgery.
J Comput Assist Tomogr
1994; 18:476-483.
89. Gelet A., Chapelon J. Y., Bouvier R., Souchon R., Pangaud
C., Abdelrahim A. F., Cathignol D., and Dubernard J. M.
Treatment of prostate cancer with transrectal focused
ultrasound: Early clinical experience.
Eur Urol
1996; 29:
174-183.
90. Foster R. S., Bihrle R., Sanghvi N. T., Fry F. J., and
Donohue J. P. High-intensity focused ultrasound in the
treatment of prostatic disease.
Eur Urol
1993; 23 (supple
1): 29-33.
91. Coleman D. J., Lizzi F. L., Driller J., Rosado A. L., Chang
S., Iwamoto T., and Rosenthal D. Therapeutic ultrasound
in the treatment of glaucoma. I. Experimental model.
Ophthalmology
1985; 92:339-346.
92. Visioli A. G., Rivens I. H., terHaar G. R., Horwich A.,
Huddart R. A., Moskovic E., Padhani A., and Glees J.
Preliminary results of a phase I dose escalation clinical
trial using focused ultrasound in the treatment of localised
tumours.
EurJUltrasound
1999; 9:11-18.
93. Wu F., Wang Z. B., Chen W. Z., Wang W., Gui Y., Zhang
M., Zheng G., Zhou Y., Xu G., Li M., Zhang C., Ye H., and
Feng R. Extracorporeal high intensity focused ultrasound
ablation in the treatment of 1038 patients with solid car-
cinomas in China: An overview.
Ultrason Sonochem
2004;
11:149-154.
94. Wu F., Wang Z. B., and Wang Z. L
.
Changes in ultrasonic
image of tissue damaged by high intensity focused ultra-
sound
in vivo
.
J Acoustic Soc
Am
1998; 103:2869.
95. Cady B., Jenkins R. L., Steele G. D., Lewis W. D., Stone M.
D., McDermott W. V., Jessup J. M., Bothe A., Lalor P., Lovett
E. J., Lavin P., and Linehan D. C. Surgical margin in hepatic
resection for colorectal metastasis: A critical and improv-
able determinant of outcome.
Ann Surg
1998; 227:566-571.
96. Farmer D. G., Rosove M. H., Shaked A., and Busuttil R. W.
Current treatment modalities for hepatocellular carcinoma.
Ann Surg
1994; 219:236-247.
97. Lin D., Lin S. M., and Liaw Y. F. Non-surgical treatment
of hepatocellular carcinoma.
J Gastroenterol Hepa
1997;
12:S319-S328.
98. Lin T. Y., Lee C. S., Chen K. M., and Chen C. C. Role of
surgery in the treatment of primary carcinoma of the liver:
A 31-year experience.
Br J Surg
1987; 74:839-842.
99. Zibari G. B., Riche A., Zizzi H. C., McMillan R.W., Aultman
D.F., Boykin K.N., Gonzalez E., Nandy I., DiesD. F.,
Gholson C.F., Holcombe R.F., and McDonald J.C. Surgical
and nonsurgical management of primary and metastatic
liver tumors.
Am Surg
1998; 64:211-221.
100. Goldberg S. N., Gszelle G. S., and Mueller P. R. Thermal
ablation therapy for focal malignancy: A unified approach
to underlying principles, techniques, and diagnostic imag-
ing guidance.
Am J Roentgenol
2000; 174:323-331.
101. Vallancien G., Harouni M., Veillon B., Mombet A.,
Prapotnich D., Brisset J. M., and Bougaran J. Focused extra-
corporeal pyrotherapy: Feasibility study in man.
J Endourol
1992; 6:173-181.
102. Wu F., Chen W. Z., Bai J., Zou J. Z., Wang Z. L., Zhu H.,
and Wang Z. B. Pathological changes in human malignant
carcinoma treated with high-intensity focused ultrasound.
Ultrasound Med Biol
2001; 27: 1099-1106.
103. Wu F., Wang Z. B., Chen W. Z., Zhu H., Bai J., Zou J. Z.,
Li K. Q., Jin C. B., Xie F. L., and Su H. B. Extracorporeal
high intensity focused ultrasound ablation in the treatment
of patients with large hepatocellular carcinoma.
Ann Surg
Oncol
2004; 11:1061-1069.
104. Wu F., Wang Z. B., Chen W. Z., Zhu H., Bai J., Zou J. Z., Li
K. Q., Jin C. B., Xie F. L., and Su H. B. Advanced hepato-
cellular carcinoma: Treatment with high-intensity focused
ultrasound ablation combined with transcatheter arterial
embolization.
Radiology
2005; 235: 659-667.
105. Li C., Zhang W., Zhang R., Zhang L., Wu P., and Zhang F.
Therapeutic effects and prognostic factors in high-intensity
focused ultrasound combined with chemoembolisation
for larger hepatocellular carcinoma.
Eur J Cancer
2010;
46:2513-2521.
106. Zhang L., Zhu H., Jin C., Zhou K., Li K., Su H., Chen W.,
Bai J., and Wang Z. High-intensity focused ultrasound
(HIFU): Effective and safe therapy for hepatocellular car-
cinoma adjacent to major hepatic veins.
Eur Radiol
2009;
19:437-445.
107. Wang Y., Wang W., Wang Y., and Tang J. Ultrasound-guided
high-intensity focused ultrasound treatment for needle-
track seeding of hepatocellular carcinoma: Preliminary
results.
Int J Hyperthermia
2010; 26:441-447.
108. Li C. X., Xu G. L., Jiang Z. Y., Li J. J., Luo G. Y., Shan H.
B., Zhang R., and Li Y. Analysis of clinical effect of high-
intensity focused ultrasound on liver cancer.
Wo r l d
J Gastroenterol
2004; 10:2201-2204.
109. Li Y. Y., Sha W. H., Zhou Y. J., and Nie Y. Q. Short and long
term efficacy of high intensity focused ultrasound therapy
for advanced hepatocellular carcinoma.
J Gastroenterol
Hepatol
2007; 22: 2148-2154.
110. Illing R. O., Kennedy J. E., Wu F., Ter Haar G. R., Protheroe
A. S., Friend P. J., Gleeson F. V., Cranston D. W., Phillips R.
R., and Middleton M. R. The safety and feasibility of extra-
corporeal high-intensity focused ultrasound (HIFU) for the
treatment of liver and kidney tumours in a Western popula-
tion.
Br J Cancer
2005; 93:890-895.
111. Leslie T. A., Kennedy J. E., Illing R. O., Ter Haar G. R., Wu
F., Phillips R. R., Friend P. J., Roberts I. S., Cranston D. W.,
and Middleton M. R. High-intensity focused ultrasound
ablation of liver tumours: Can radiological assessment pre-
dict the histological response?
Br J Radiol
2008; 81:564-571.
